Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Recherche
  • icone plus

  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte

  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités

1 result

  • Type : Health technology assessment
  • Active substance : silodosine
  • Active substance : aspirine
Filter
Topic
  • Economics and public health (1)
  • Plus ...
    • Health economics (1)
  • Diagnostic and therapeutic techniques (1)
  • Plus ...
    • Surgical procedures (1)
    • Plus ...
      • Urogenital surgery (1)
  • Diseases and conditions (1)
  • Plus ...
    • Urologic diseases (1)
    • Plus ...
      • Urination disorders (1)
    • Genital diseases (1)
    • Plus ...
      • Male genital diseases (1)
Content type
  • Drugs, devices and medical acts (1)
  • Plus ...
    • Health technology assessment (1)
Manufacturer
  • inconnu (1)
  • industriels (1)
Language
  • Français (1)
Active substance
  • aluminium (1)
  • aspirine (1)
  • clopidogrel (1)
  • doxazosine (1)
  • lithium (1)
  • mannitol (1)
  • phosphate (1)
  • potassium (1)
  • silodosine (1)
  • tamsulosine (1)
 More filter Other Filter Icon
Search Export
  • « Première page
  • < Page précédente
  • / 1
  • > Page suivante
  • » Dernière page
Sorted by :Relevance
  • Title
  • Date

  • Laser treatment of lower urinary tract symptoms associated with benign prostatic

    Health technology assessment - Posted on 12/12/2013
    Add to my selection
  • « Première page
  • < Page précédente
  • / 1
  • > Page suivante
  • » Dernière page
  • 50 par pages
    • 10 par pages
    • 20 par pages
    • 50 par pages
    • 100 par pages

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
jXzDmyEuAzdXRdA2